Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Mackensen

Showing results (101-110 of 196) with videos related to

Pageof 20
Sort By:
The Journal of Clinical Investigation|June 18, 2019
Chaperone protein HSC70 regulates intercellular transfer of Y chromosome antigen DBYSascha Kretschmann, Stefanie Herda, Heiko Bruns, et al.
International Journal of Cancer|July 8, 2010
Warburg phenotype in renal cell carcinoma: high expression of glucose-transporter 1 (GLUT-1) correlates with low CD8(+) T-cell infiltration in the tumorKatrin Singer, Michael Kastenberger, Eva Gottfried, et al.
Zeitschrift Fur Rheumatologie|September 4, 2025
[Long-term follow up of efficiency and safety of CD19-CAR T-cell treatment of systemic lupus erythematosus]Jule Taubmann, Sebastian Böltz, Melanie Hagen, et al.
Stem Cells (Dayton, Ohio)|February 4, 2021
Protein kinase C-β-dependent changes in the glucose metabolism of bone marrow stromal cells of chronic lymphocytic leukemiaFranziska von Heydebrand, Maximilian Fuchs, Meik Kunz, et al.
International Journal of Molecular Sciences|January 25, 2025
Exploring CAR T-Cell Dynamics: Balancing Potent Cytotoxicity and Controlled Inflammation in CAR T-Cells Derived from Systemic Sclerosis and Myositis PatientsJanin Dingfelder, Jule Taubmann, Franziska von Heydebrand, et al.
Cancers|December 24, 2021
An Easily Expandable Multi-Drug LC-MS Assay for the Simultaneous Quantification of 57 Oral Antitumor Drugs in Human PlasmaNiklas Kehl, Katja Schlichtig, Pauline Dürr, et al.
Blood|May 23, 2014
CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegsRegina Jitschin, Martina Braun, Maike Büttner, et al.
Molecular Cancer Research : MCR|May 3, 2022
Midkine Promotes Metastasis and Therapeutic Resistance via mTOR/RPS6 in Uveal MelanomaMargarete M Karg, Lukas John, Nasrin Refaian, et al.
Cell Death & Disease|August 25, 2023
Targeted inhibition of protein synthesis renders cancer cells vulnerable to apoptosis by unfolded protein responseFranziska Gsottberger, Christina Meier, Anna Ammon, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|December 11, 2012
Major histocompatibility complex class II polymorphisms are associated with the development of anti-resorptive agent-induced osteonecrosis of the jawPhilipp Stockmann, Emeka Nkenke, Matthias Englbrecht, et al.
Pageof 20

Showing results (101-110 of 196) with videos related to

Sort By:
Pageof 20
The Journal of Clinical Investigation|June 18, 2019
Chaperone protein HSC70 regulates intercellular transfer of Y chromosome antigen DBYSascha Kretschmann, Stefanie Herda, Heiko Bruns, et al.
International Journal of Cancer|July 8, 2010
Warburg phenotype in renal cell carcinoma: high expression of glucose-transporter 1 (GLUT-1) correlates with low CD8(+) T-cell infiltration in the tumorKatrin Singer, Michael Kastenberger, Eva Gottfried, et al.
Zeitschrift Fur Rheumatologie|September 4, 2025
[Long-term follow up of efficiency and safety of CD19-CAR T-cell treatment of systemic lupus erythematosus]Jule Taubmann, Sebastian Böltz, Melanie Hagen, et al.
Stem Cells (Dayton, Ohio)|February 4, 2021
Protein kinase C-β-dependent changes in the glucose metabolism of bone marrow stromal cells of chronic lymphocytic leukemiaFranziska von Heydebrand, Maximilian Fuchs, Meik Kunz, et al.
International Journal of Molecular Sciences|January 25, 2025
Exploring CAR T-Cell Dynamics: Balancing Potent Cytotoxicity and Controlled Inflammation in CAR T-Cells Derived from Systemic Sclerosis and Myositis PatientsJanin Dingfelder, Jule Taubmann, Franziska von Heydebrand, et al.
Cancers|December 24, 2021
An Easily Expandable Multi-Drug LC-MS Assay for the Simultaneous Quantification of 57 Oral Antitumor Drugs in Human PlasmaNiklas Kehl, Katja Schlichtig, Pauline Dürr, et al.
Blood|May 23, 2014
CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegsRegina Jitschin, Martina Braun, Maike Büttner, et al.
Molecular Cancer Research : MCR|May 3, 2022
Midkine Promotes Metastasis and Therapeutic Resistance via mTOR/RPS6 in Uveal MelanomaMargarete M Karg, Lukas John, Nasrin Refaian, et al.
Cell Death & Disease|August 25, 2023
Targeted inhibition of protein synthesis renders cancer cells vulnerable to apoptosis by unfolded protein responseFranziska Gsottberger, Christina Meier, Anna Ammon, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|December 11, 2012
Major histocompatibility complex class II polymorphisms are associated with the development of anti-resorptive agent-induced osteonecrosis of the jawPhilipp Stockmann, Emeka Nkenke, Matthias Englbrecht, et al.
Pageof 20